Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops and commercializes branded prescription products designed to improve quality of care and address unmet medical needs.

With a focus on underserved niche markets, including hospital acute care and gastroenterology, they deliver products that serve patients in the U.S. market. Cumberland also makes its products available to patients internationally through select strategic partnerships.

They own the worldwide rights to all their brands. While Cumberland’s commercial capabilities are focused on the U.S. market, their business development team is actively pursuing opportunities to make their brands available to patients in markets around the globe.

Their primary mission is to improve upon patient care with products that offer clear advantages over existing treatments. They also strive to deliver solutions that may help reduce costs for healthcare providers and, ultimately, patients. 

Pharmaceutical

Cumberland Pharmaceuticals

A.J. Kazimi

Emily Palmer

Maruf Sarwar

Luke Mengak

Jay Quinn

Chris Bitterman

James L. Herman

Tan Cheow Choon

Barry Lee

Adam S. Mostafa

Todd Anthony

The current leadership team at Cumberland Pharmaceuticals has a wealth of experience in the pharmaceutical industry. The team is composed of individuals who have worked for companies such as Solvay Pharmaceuticals and Schwarz Pharma. In addition, the team members have degrees from institutions such as Cardinal Stritch University. This combination of experience and education gives the team the ability to successfully navigate the ever-changing landscape of the pharmaceutical industry.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Cumberland Pharmaceuticals

Board of Directors

CEO and Executive Team